|
Age at clinic (years)
|
24.0 (21.5–38.5)
|
37.0 (24.0-51.3)*
|
|
Age at diagnosis (years)
|
18.0 (11.0-25.5)
|
16.5 (9.0–29.0)
|
|
Diabetes duration (years)
|
9.0 (2.0–17.0)
|
14.0 (8.8–26.5)*
|
|
Female [n (%)]
|
22 (49)
|
29 (47)
|
|
Body weight (kg)
|
64.0 (61.1–74.3)
|
80.5 (73.1–94.2)*
|
|
BMI (kg/m2)
|
22.9 (20.7–24.3)
|
29.1 (25.3–34.1)*
|
|
HbA1c (mmol/mol)
|
63.0 (53.5–73.0)
|
72.5 (66.8–87.0)*
|
|
Total Insulin dose (units)
|
42.0 (30.8–54.5)
|
57.0 (42.3–80.5)*
|
|
Insulin dose (unit/kg/day)
|
0.65 (0.45–0.82)
|
0.71 (0.56–0.93)*
|
|
Total Cholesterol (mmol/L)
|
4.1 (3.5–4.9)
|
4.4 (3.6-5.0)
|
|
Triglyceride (mmol/L)
|
0.9 (0.6–1.3)
|
1.3 (0.9–1.8)*
|
|
HDL Cholesterol (mmol/L)
|
1.6 (1.3–1.9)
|
1.4 (1.1–1.7)*
|
|
LDL Cholesterol (mmol/L)
|
2.0 (1.6–2.5)
|
2.5 (1.8–3.2)
|
|
Hypertension, [n (%)]
|
0 (0)
|
20 (32)*
|
|
Statins [n (%)]
|
10 (22)
|
23 (37)
|
|
ACEI/ARB [n (%)]
|
3 (7)
|
19 (31)*
|
|
Metformin [n (%)]
|
5 (11)
|
9 (15)
|
|
Microalbuminuria, [n (%)]
|
2 (4.4)
|
15 (24)*
|
|
eGDR
|
8.9 (8.5–10.0)
|
6.1 (4.5–7.3)*
|
